Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
Medpage Today on MSN
First 7-Year Report of Low-Risk TAVR Reassures, With Finish Line Now in Sight
SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those ...
6don MSN
Minimally invasive procedure for aortic valve disease has similar outcomes as surgery, study reports
People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes ...
Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.
Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.
Medtronic today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.
A troubling rise in severe diverticulitis cases among Americans under 50 highlights a significant public health concern.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback